Paige Cerulli |
December 26, 2020
Social distancing protocols require finding alternative ways to keep residents socially connected and engaged.
Read More »
Paige Cerulli |
November 28, 2020
We’re pleased to share new evidence of the MMR vaccine’s effectiveness against COVID-19.
Read More »
Paige Cerulli |
October 7, 2020
The SHINE program takes a unique approach to memory care, and it was recently recognized by the Alzheimer’s Association for its work.
Read More »
Paige Cerulli |
October 6, 2020
A new clinical trial assesses the safety and effectiveness of LY-CoV555, an antibody against SARS-CoV-2, the virus that causes COVID-19.
Read More »
Paige Cerulli |
July 27, 2020
Because of the pandemic, letting residents go outside requires more thought and planning than it has in previous years. But it's still highly worthwhile.
Read More »
Paige Cerulli |
March 26, 2020
Guidelines for preventing COVID-19 and managing coronavirus infection in senior care facilities are rapidly evolving. Read on for the latest.
Read More »
The Montreal Parkinson Risk of Dementia Scale (MoPaRDS), which comprises 8 simple clinical variables, is effective for predicting the risk for dementia in patients with Parkinson disease(PD), according to findings from a multicenter study published in JAMA Neurology.
Read More »
One of the largest gifts in Brown University history, from Brown graduate Robert J. Carney and his wife, Nancy D. Carney, is intended to quicken the pace of neuroscience research in R.I., with the potential to develop new treatments and cures for such devastating conditions as Alzheimer’s disease and amyotrophic lateral sclerosis, or ALS.
Read More »
Pamela Tabar |
December 18, 2017
The buildup of a specific chemical in the brain is an early sign of Huntington's dementia, and it could help with early detection of Alzheimer's disease and other dementias, says a new study.
Read More »
Pamela Tabar |
November 8, 2017
Advocacy groups say the government’s £132 million funding for Alzheimer’s research needs to be doubled for at least the next five years.
Read More »
Pamela Tabar |
October 16, 2017
Research breakthrough: Scientists have identified symptoms that could lead to earlier diagnosis of Lewy body mild cognitive impairment.
Read More »
Pamela Tabar |
October 12, 2017
The study is the latest attempt to develop better olfactory tests that might be used to detect early stages of neurodegeneration.
Read More »
Pamela Tabar |
October 4, 2017
The study will use sensors, wearables and even gut bacteria to study how seniors with mild cognitive impairment think and remember.
Read More »
Pamela Tabar |
August 21, 2017
A Canadian study has connected memory loss and a confused nose. Could it lead to earlier detection of Alzheimer’s disease?
Read More »
Pamela Tabar |
July 31, 2017
Researchers examine a new assessment test to determine a resident’s risk of age-related muscle and skeletal loss called sarcopenia.
Read More »
Pamela Tabar |
July 31, 2017
Sleep-disordered breathing may affect cognition, especially in those who carry the APOE-4 gene, thought to be a genetic risk factor for Alzheimer's.
Read More »
Pamela Tabar |
July 30, 2017
The university will lead a 10-site examination of risk factors and the role of genetics in cognitive decline among Latinos.
Read More »
A recent Food and Drug Administration analysis found it’s difficult to practice evidence-based medicine for seniors because there isn’t enough data on how treatments may affect them.
Read More »
Those with the movement disorder are nearly four times more likely to have skin cancer in their history, while those who have had skin cancer may have a higher risk of developing Parkinson's disease, a new study finds.
Read More »
Pamela Tabar |
July 10, 2017
Why is dementia research so complex? Why don't we have a cure yet? Many researchers now think the most important part of the dementia story comes long before symptoms appear.
Read More »
Nicole Stempak |
June 30, 2017
New research published in JAMA found people can have Alzheimer’s disease many years before cognitive impairment sets in, meaning disease estimates could be way off.
Read More »
Pamela Tabar |
June 30, 2017
Does Lewy Body Dementia have a biological calling card? Cleveland Clinic is launching a national consortium to find out.
Read More »
Advances in medical imaging allow researchers to see brain tissue destruction and the presence of telltale biomarkers of cognitive disease. But what if you could capture both in a single image?
Read More »
Pamela Tabar |
June 13, 2017
The brain deterioration associated with multiple sclerosis can hinder a person’s ability to interact with an accurate social context, says a new study in Neurology journal.
Read More »
Pamela Tabar |
May 15, 2017
Researchers are taking a harder look at how spikes in blood glucose can affect dementia risks.
Read More »
Pamela Tabar |
May 8, 2017
Although the terms are sometimes confused among lay people, the two conditions often develop independently from each other. Having both can cause the fastest decline of all, a new study shows.
Read More »
Pamela Tabar |
February 27, 2017
The white paper describes 39 innovative programs that are changing the way providers deliver quality care for those with dementia.
Read More »
Pamela Tabar |
February 22, 2017
Researchers have designed a new tool to assess how elder-friendly a dining space is. Turns out, healthy dining for older adults is about a lot more than food. How would your dining venues rate?
Read More »
